AARD Aardvark Therapeutics, Inc.: institutional ownership and insider trading
72 funds reported holding $64.2M of Aardvark Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $4.25M, with 17 new positions and 24 funds selling out; over the last 12 months insiders bought $145K and sold $395K on the open market.
Famous investors holding AARD
- Ken Griffin (Citadel Advisors): $7.73M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $624K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $403K, 0.0% of the portfolio
Largest institutional holders of AARD
- Decheng Capital LLC — $22.6M
- VANGUARD GROUP INC — $9.42M
- CITADEL ADVISORS LLC — $7.73M
- Laurion Capital Management LP — $5.96M
- VANGUARD CAPITAL MANAGEMENT LLC — $3.24M
- AQR CAPITAL MANAGEMENT LLC — $2.77M
- EcoR1 Capital, LLC — $2.37M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $1.73M
- BlackRock, Inc. (BLK) — $1.08M
- GEODE CAPITAL MANAGEMENT, LLC — $864K
Recent AARD insider trades
- Sep 11, 2026: Sun Nelson sold 76,754 shares ($395K)
- Dec 11, 2025: Lee Tien-Li bought 7,000 shares ($101K)
- Dec 11, 2025: Sun Nelson bought 3,000 shares ($43.2K)
- Sep 15, 2025: Lee Tien-Li bought 10,000 shares ($96.6K)
5%+ owners
- Xiangmin Cui: 18.3% (Schedule 13G, filed Feb 24, 2025)
- Tien-Li Lee: 13.7% (Schedule 13G, filed May 15, 2025)
- Vickers Venture Fund VI Pte. Ltd.: 9.6% (Schedule 13G, filed Feb 24, 2025)
- Kenneth Griffin: 5.6% (Schedule 13G, filed Feb 24, 2025)